Bhaskar Chaudhuri - Apr 20, 2021 Form 4/A - Amendment Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Director
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Bhaskar Chaudhuri
Stock symbol: ARQT
Transactions as of: Apr 20, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 5/12/2021, 06:19 PM
Date Of Original Report: Apr 22, 2021
Next filing: Jun 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARQT	Common Stock						871K	Apr 20, 2021	Direct	F1
holding	ARQT	Common Stock						50K	Apr 20, 2021	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale transactions originally reported on lines 1 and 2 of the Form 4 filed by the Reporting Person on 4/22/2021 did not occur. This Form 4/A corrects the aforementioned error by removing the transactions and adjusting the Reporting Person's direct ownership accordingly.
F2	The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Content

The sale transactions originally reported on lines 1 and 2 of the Form 4 filed by the Reporting Person on 4/22/2021 did not occur. This Form 4/A corrects the aforementioned error by removing the transactions and adjusting the Reporting Person's direct ownership accordingly.

The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.